高级官员埃里克·杜贝（Eric Dube）计划出售价值 180 万美元的股票，同时正在进行内部分配
summarizeSummary
This Form 144 filing by Officer Eric M. Dube signals a continued pattern of share distribution by the insider, following previous sales totaling over $5 million in the past three months. While the proposed sale of $1.8 million is a relatively small percentage of the company's market capitalization, the consistent insider selling by an officer could be perceived negatively by investors, especially coming shortly after the company's 10-K filing highlighted strong financial performance. This ongoing distribution suggests a reduction in insider exposure.
check_boxKey Events
-
拟议股票出售
高级官员埃里克·M·杜贝打算出售 60,000 股普通股，价值约 1800 万美元。
-
持续内部人员分配
本次提交的文件遵循了杜贝先生过去三个月内超过500万美元的股票出售，表明了持续的股票处置模式。
-
高管级交易
该填报人，Eric M. Dube，担任Travere Therapeutics, Inc.的高管职位。
auto_awesomeAnalysis
This Form 144 filing by Officer Eric M. Dube signals a continued pattern of share distribution by the insider, following previous sales totaling over $5 million in the past three months. While the proposed sale of $1.8 million is a relatively small percentage of the company's market capitalization, the consistent insider selling by an officer could be perceived negatively by investors, especially coming shortly after the company's 10-K filing highlighted strong financial performance. This ongoing distribution suggests a reduction in insider exposure.
在该文件披露时，TVTX的交易价格为$30.39，交易所为NASDAQ，所属行业为Life Sciences，市值约为$27.2亿。 52周交易区间为$12.91至$42.13。 这份文件被评估为消极市场情绪，重要性评分为7/10。